PharmTech News

Articles

Boehringer Ingelheim will combine assets from its cancer immunology portfolio with the KISIMA immunization platform from AMAL Therapeutics.

Boehringer Ingelheim Acquires Immunotherapy Platform

 Gilead Sciences gains rights to clinical and preclinical programs in Galapagos’ portfolio through a 10-year global research and development collaboration.

Gilead and Galapagos Announce Global R & D Collaboration

Slovakia becomes the final European Union country to be recognized by FDA, and the mutual recognition agreement for inspections of manufacturing sites between the US and the EU is now fully implemented. 

US and Europe Reach Mutual Recognition Agreement Goal on Inspections

More than 30 lots of losartan drug products have been recalled due to contaminated API manufactured by Hetero Labs.

Macleods Issues Recall Due to NMBA Impurities

Three months following his departure from FDA, former commissioner Scott Gottlieb joins Pfizer’s board of directors. 

Gottlieb Elected to Pfizer’s Board

In anticipation of the loss of patent exclusivity for Humira, AbbVie makes $63-billion move to acquire Allergan. 

AbbVie Announces $63 Billion Allergan Acquisition

Pfizer’s acquisition of Array BioPharma expands the company’s pipeline of investigational cancer therapies.

Pfizer to Acquire Array BioPharma

The acquisition will boost Merck’s pipeline for cancer, fibrosis, and autoimmune disease therapeutics.

Merck & Co. to Acquire Tilos Therapeutics in Deal Worth Up to $773 Million

The current president of Novartis’ Advanced Accelerator Applications has been appointed as the new Novartis Pharmaceuticals president.

Novartis Announces New Head of Pharmaceuticals Business Unit

The acquisition will boost Biogen’s gene-therapy pipeline with the addition of two mid- to late-stage clinical assets and preclinical programs.

Top News